Bangladesh’s state-run life insurer, Jiban Bima Corporation (JBC), has implemented a stringent set of underwriting regulations that strictly exclude individuals with pre-existing medical conditions, high-risk occupations, and undisclosed health histories from acquiring supplementary insurance benefits, widely known in the industry as riders. Under these revised terms, applicants are now legally required to provide full medical disclosures and certified diagnostic reports prior to securing any additional coverage.
The national insurer released a comprehensive 14-point directive on 26 July, detailing the operational requirements designed to standardise risk management across its operational structure. The instructions have been formally dispatched to all corporate, regional, sales, and branch offices for immediate execution.
Enhancing Policy Transparency and Rider Provisions
In the insurance sector, a rider represents an optional policy add-on purchased alongside a base life insurance contract to extend financial protection against specific risks, such as critical illness, hospitalisation, or accidental death. It cannot exist as an independent contract; rather, its validity depends directly on the main life policy. For example, a policyholder carrying a base life cover of ৳2 million who incorporates a ৳1 million accidental death rider would provide their named beneficiary with a potential total payout of ৳3 million in the event of a fatal accident. JBC offers a variety of these supplementary options, including health cover, major disease protection, and waiver-of-premium provisions.
To establish uniform principles and eliminate previous ambiguities in claim settlements, JBC’s directive outlines clear operational conditions:
Strict Eligibility Criteria: Rider benefits are restricted exclusively to individuals who are healthy, physically active, and fit for work. Coverage is explicitly denied to anyone diagnosed with severe illnesses, including cancer, heart disease, stroke, renal failure, liver cirrhosis, or paralysis.
Exclusion of Chronic Conditions: Individuals suffering from HIV/AIDS, congenital anomalies, long-term chronic illnesses, or severe lifestyle-related conditions are disqualified from receiving rider protection.
Mandatory Medical Screenings: Prospective policyholders must submit formal diagnostic reports, including lipid profiles and serum creatinine checks, upon request. JBC reserves the authority to mandate additional clinical tests or physician certificates. Any applicant hospitalised or treated for a critical condition within the preceding two years will undergo detailed clinical evaluations before consideration.
Occupational and Disability Exclusions: Health, critical illness, and premium waiver riders will not be extended to individuals with existing permanent or partial physical or mental disabilities. Furthermore, individuals employed in dangerous occupations, high-risk trades, or hazardous sports are barred from supplementary coverage.
Dependent Policy Status: Because rider protection is subsidiary to the primary contract, any lapse, surrender, or cancellation of the core life policy will result in the immediate termination of all attached rider benefits.
Addressing Structural Inefficiencies and Non-Disclosure
The regulatory reform addresses long-standing systemic issues within the state enterprise. Officiating Managing Director Sayeed Khutub—who concurrently serves as Additional Secretary within the Financial Institutions Division of the Ministry of Finance—confirmed that the new policy was introduced to curb systemic malpractices and irregularities surrounding rider approvals.
Insiders report that branch offices had previously been approving supplementary coverage arbitrarily without enforcing mandatory health checks or evaluating job-related hazards. Consequently, numerous policyholders acquired riders while concealing existing health conditions, leading to widespread contractual disputes and claim rejections during the settlement phase. Under the enforced measures, any deliberate concealment or misrepresentation of medical history will result in immediate claim repudiations alongside statutory legal measures.
This policy overhaul arrives during a key transition in leadership at JBC. The corporation’s Chairman, Md. Mokhles ur Rahman, recently submitted his resignation, which remains pending approval at the Prime Minister’s Office, while the organization continues to function without a permanent managing director. Insurers anticipate that these structured guidelines will enforce institutional discipline, safeguard public funds, and ensure fairer claim settlements across the nation.
